By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell Receives EU Orphan Drug Designation For Col-Treg In The Treatment Of Non-Infectious Uveitis 12/17/2014 11:01:32 AM
TxCell To Present At EU Advanced Therapies Investor Day November 13, In London, UK 11/7/2014 10:56:01 AM
TxCell Reports Revenues For The Third Quarter Of 2014 11/4/2014 12:22:10 PM
TxCell Achieves Positive Results For Col-Treg In A Model Of Autoimmune Uveitis 10/28/2014 6:35:12 AM
TxCell To Present On T Cellular Therapy For Autoimmune Diseases At The 7th National Bio-Therapy Conference 2014, China 10/16/2014 1:00:28 PM
TxCell To Present Latest Developments Of Its Personalized Cell-Based Immunotherapy Platform, Astria, At The 13th TxCell Investor Forum 2014 10/2/2014 9:29:35 AM
TxCell Financial Results For The First Half Of 2014 9/24/2014 11:12:04 AM
TxCell To Participate At Société Générale Healthcare & Biotechnology Conference, Paris 9/22/2014 12:30:46 PM
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014 8:26:52 AM
TxCell To Lead Positive Project To Automate First Production Step Of Ovasave®, Its Lead Personalised Cellular Immunotherapy 7/3/2014 8:47:12 AM